{
      "title": "CLINICAL AND LABORATORY FEATURES IN PATIENTS RECOVERED FROM COVID-19 PNEUMONIA",
      "status_changed": "2026-05-26 15:56:06",
      "abstract": "The post-acute sequelae of SARS-CoV-2 infection (Long COVID) represent a growing global health challenge. While acute phase laboratory changes are well-documented, the persistence of hematological and biochemical abnormalities months after recovery from COVID-19 pneumonia remains insufficiently characterized, particularly in the Central Asian population. A retrospective, cross-sectional cohort study was conducted involving 120 participants. The primary group consisted of 80 patients who had recovered from moderate to severe COVID-19 pneumonia 3 to 6 months prior to the study. The control group included 40 healthy individuals with no history of SARS-CoV-2 infection. Clinical data, complete blood counts, coagulation profiles, and systemic inflammatory markers were analyzed. Statistical evaluation was performed using the Student\u2019s t-test and chi-square test. Patients in the post-COVID group demonstrated persistent laboratory alterations compared to the control group. Statistically significant elevations were observed in D-dimer (0.65 \u00b1 0.08 mg/L vs. 0.22 \u00b1 0.04 mg/L, p < 0.001), C-reactive protein (8.4 \u00b1 1.2 mg/L vs. 2.5 \u00b1 0.5 mg/L, p < 0.01), and ferritin (245 \u00b1 25 mcg/L vs. 110 \u00b1 15 mcg/L, p < 0.01). Furthermore, relative lymphopenia (21.5 \u00b1 1.8% vs. 32.4 \u00b1 2.1%, p < 0.05) remained prevalent in the recovered cohort. Recovery from the acute phase of COVID-19 pneumonia does not equate to complete physiological normalization. Persistent systemic inflammation and subclinical endotheliopathy can last for months, necessitating long-term clinical and laboratory monitoring to prevent delayed cardiovascular and pulmonary complications.",
      "creators": [
        {
          "name": {
            "family": "Umurzaqova",
            "lineage": null,
            "honourific": null,
            "given": "R.Z."
          }
        },
        {
          "name": {
            "family": "Axmatjonova",
            "lineage": null,
            "given": "F.D.",
            "honourific": null
          }
        }
      ],
      "eprintid": 66018,
      "keywords": "COVID-19 pneumonia, Post-acute COVID-19 syndrome, Long COVID, D-dimer, Inflammatory markers, Endothelial dysfunction, Biomarkers.",
      "sword_depositor": 1,
      "dir": "disk0/00/06/60/18",
      "publication": "Multidisciplinary Journal of Science and Technology",
      "lastmod": "2026-05-26 15:56:06",
      "eprint_status": "archive",
      "publisher": "Center for Tech and Media Research",
      "rev_number": 1,
      "datestamp": "2026-05-26 15:56:06",
      "ispublished": "pub",
      "date_type": "published",
      "metadata_visibility": "show",
      "note": "Imported from MJST Journal (OAI id oai:ojs.pkp.sfu.ca:article/7000)",
      "userid": 1,
      "official_url": "https://mjstjournal.com/index.php/mjst/article/view/7000",
      "subjects": [
        "COVID-19 pneumonia, Post-acute COVID-19 syndrome, Long COVID, D-dimer, Inflammatory markers, Endothelial dysfunction, Biomarkers."
      ],
      "type": "article",
      "full_text_status": "none",
      "id_number": "oai:ojs.pkp.sfu.ca:article/7000",
      "date": "2026-03-13",
      "uri": "https://arxiv.universalpublishings.com/id/eprint/66018"
    }